{"id":3100,"date":"2014-01-10T06:22:21","date_gmt":"2014-01-10T04:22:21","guid":{"rendered":"http:\/\/www.ced.org.tr\/?p=3100"},"modified":"2014-01-10T06:22:21","modified_gmt":"2014-01-10T04:22:21","slug":"japonlar-novartisten-sikayetci","status":"publish","type":"post","link":"http:\/\/www.ced.org.tr\/?p=3100","title":{"rendered":"Japonlar Novartis’ten \u015fikayet\u00e7i"},"content":{"rendered":"
\u00d6nde gelen \u0130svi\u00e7reli ila\u00e7 \u00fcretim firmas\u0131 Novartis’in ba\u015f\u0131, ikinci b\u00fcy\u00fck pazar\u0131 olan Japonya ile derde girdi.<\/span><\/h5>\n

Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131, \u00fclkede yayg\u0131n olarak tercih edilen Diovan ad\u0131ndaki tansiyon ilac\u0131n\u0131n \u2018\u00fczerinde oynanm\u0131\u015f ara\u015ft\u0131rma\u2019 sonu\u00e7lar\u0131 kullan\u0131larak pazarland\u0131\u011f\u0131 gerek\u00e7esiyle firma hakk\u0131nda su\u00e7 duyurusunda bulundu.<\/span><\/p>\n

09\/01\/2014 Radikal<\/p>\n

<\/span><\/p>\n

http:\/\/www.radikal.com.tr\/ekonomi\/japonlar_novartisten_sikayetci-1170083<\/span><\/a><\/span><\/p>\n

Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131, \u00fclkede yayg\u0131n olarak tercih edilen Diovan ad\u0131ndaki tansiyon ilac\u0131n\u0131n \u2018\u00fczerinde oynanm\u0131\u015f ara\u015ft\u0131rma\u2019 sonu\u00e7lar\u0131 kullan\u0131larak pazarland\u0131\u011f\u0131 gerek\u00e7esiyle firma hakk\u0131nda su\u00e7 duyurusunda bulundu. Bas\u0131n toplant\u0131s\u0131 d\u00fczenleyen yetkililer, Japonya\u2019da ilk kez eczac\u0131lar ve eczaneler hakk\u0131ndaki kanun uyar\u0131nca dava a\u00e7\u0131ld\u0131\u011f\u0131n\u0131 vurgulad\u0131. Ge\u00e7en y\u0131l ila\u00e7 \u00fczerinde ara\u015ft\u0131rma yapan \u00fcniversiteler klinik verilerin hatal\u0131 oldu\u011funu fark edince \u00e7al\u0131\u015fmalar\u0131n\u0131 yar\u0131da kesmi\u015fti. Baz\u0131 hastaneler de \u00e7\u0131kan tart\u0131\u015fmalar sonucu Diovan\u2019\u0131 re\u00e7ete etmeyi durdurmu\u015flard\u0131. <\/span>
Novartis ise \u00e7al\u0131\u015fanlar\u0131ndan birinin \u2018hatal\u0131 davrand\u0131\u011f\u0131n\u0131\u2019 kabul ederken y\u00f6netimin ara\u015ft\u0131rmac\u0131lara yanl\u0131\u015f veriler g\u00f6nderilmesi emri verdi\u011fi iddias\u0131n\u0131 reddetti. Novartis\u2019in internet sitesi \u00fczerinden yap\u0131lan a\u00e7\u0131klamada da \u201cHastalardan, ailelerden, t\u0131p d\u00fcnyas\u0131ndan ve halktan verdi\u011fimiz rahats\u0131zl\u0131k i\u00e7in \u00f6z\u00fcr dileriz. Bakanl\u0131k\u2019\u0131n att\u0131\u011f\u0131 bu ad\u0131m \u2018olduk\u00e7a ciddi.\u2019 Biz de yetkililerle i\u015fbirli\u011fi yapmaya s\u00f6z veriyoruz\u201d denildi.
Firma su\u00e7lu bulunur ve h\u00fck\u00fcm giyerse 19 bin dolarl\u0131k para cezas\u0131na \u00e7arpt\u0131r\u0131lacak. \u0130htimaller aras\u0131nda m\u00fcd\u00fcrlerin 2 y\u0131la kadar hapse mahkum edilmesi de var. (TOKYO\/ WSJ- BLOOMBERG)<\/span><\/p>\n

<\/p>\n

<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

\u00d6nde gelen \u0130svi\u00e7reli ila\u00e7 \u00fcretim firmas\u0131 Novartis’in ba\u015f\u0131, ikinci b\u00fcy\u00fck pazar\u0131 olan Japonya ile derde girdi. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131, \u00fclkede yayg\u0131n...<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[62],"tags":[],"class_list":["post-3100","post","type-post","status-publish","format-standard","hentry","category-sagliktan-haberler"],"aioseo_notices":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/3100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3100"}],"version-history":[{"count":0,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/3100\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3100"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}